Yong Qing Cheng
Chief Executive Officer at Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Zheng Yu Yan | M | 63 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
 Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 25 years |
| Han Wen Chen | M | 56 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 6 years |
| Bao Qun Fan | M | 52 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 3 years |
| Jin Yi Liu | M | 55 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 25 years |
| Jia Cao | M | 40 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 10 years |
| Jun Yang Yu | M | 49 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 24 years |
| Wei Jiong Zhang | M | 71 |
China Europe International Business School
| 27 years |
| Shi Qing Cheng | M | 65 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 3 years |
| Da Hai Xu | M | 62 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 25 years |
| Feng Qin Zhang | F | 54 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 22 years |
| Da Jun Yang | M | 61 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 3 years |
| Bing Bing Wang | F | 44 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Yun De Hou | M | - |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 6 years |
| Yao Han Shen | M | 68 |
China Europe International Business School
| 2 years |
| Jerry Fan | M | 58 |
China Europe International Business School
| 2 years |
| Jing Qi Tian | M | 60 |
China Europe International Business School
| 2 years |
| Yi Min Wang | M | 73 |
China Europe International Business School
| 2 years |
| Wen Jiang Chen | F | 54 |
China Europe International Business School
| 2 years |
| Jie Feng | M | 67 |
China Europe International Business School
| 2 years |
| Chao Min Guo | M | 66 |
China Europe International Business School
| 2 years |
| Jian Min Zheng | M | 60 |
China Europe International Business School
| 3 years |
| Kai Gong | M | 68 |
China Europe International Business School
| 2 years |
| Sheng Li Rong | M | 54 |
China Europe International Business School
| 2 years |
| Jing Li | M | 54 |
China Europe International Business School
| 2 years |
| Qing Yu Zhang | M | 55 |
China Europe International Business School
| 2 years |
| Jian Rong Qian | M | 58 |
China Europe International Business School
| 2 years |
| Xue Zhong Yu | M | 66 |
Peking Union Medical College
| 1 years |
| Jian Guan | M | 55 |
China Europe International Business School
| 1 years |
| Jie Huang | M | 58 |
China Europe International Business School
| 2 years |
| Chao Xu | M | 69 |
China Europe International Business School
| 2 years |
| Yao Wang | M | 50 |
China Europe International Business School
| 2 years |
| Yan Fa Xu | M | 61 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 4 years |
| Ning Xu | M | 59 |
Peking Union Medical College
| 4 years |
| Ying Jie Zhong | F | 56 |
China Europe International Business School
| 2 years |
| Hua Huang | F | 55 |
China Europe International Business School
| 2 years |
| Chun Yan Wang | M | 59 |
Peking Union Medical College
| 2 years |
| Jian Kang Zhang | M | 66 |
China Europe International Business School
| 2 years |
| Jianhua Gao | M | 62 |
China Europe International Business School
| 2 years |
| Bin Hua | M | 52 |
China Europe International Business School
| 2 years |
| Fei Zhang | M | 51 |
China Europe International Business School
| 2 years |
| Lu Jin | M | 60 |
China Europe International Business School
| 2 years |
| Wei Hou | M | 56 |
China Europe International Business School
| 2 years |
| Zhaogang Chai | M | 58 |
China Europe International Business School
| 2 years |
| Qin Liu | M | 51 |
China Europe International Business School
| 2 years |
| Li Xia Tan | F | 54 |
China Europe International Business School
| 2 years |
| Yulin Zhi | M | 58 |
China Europe International Business School
| 2 years |
| Wen Bo He | M | 69 |
China Europe International Business School
| 2 years |
| De Shu Liu | M | 71 |
China Europe International Business School
| 2 years |
| Jian Yu Cheng | F | 66 |
China Europe International Business School
| 2 years |
| Zhi Dong Li | M | 58 |
China Europe International Business School
| 2 years |
| Zhou Miao Gao | M | 56 |
China Europe International Business School
| 2 years |
| Guang Dao Rong | M | 67 |
China Europe International Business School
| 2 years |
| Wei De Luo | M | 68 |
China Europe International Business School
| 2 years |
| Cheng Yu Mao | M | 53 |
China Europe International Business School
| 2 years |
| Su Yang Zhang | M | 65 |
China Europe International Business School
| 2 years |
| Yue Ji | M | 51 |
China Europe International Business School
| 2 years |
| He Yi Xu | M | 67 |
China Europe International Business School
| 2 years |
| Ming Li | M | 60 |
China Europe International Business School
| 2 years |
| Feng Xiao | M | 51 |
China Europe International Business School
| 2 years |
| Feng Sheng Che | M | 63 |
China Europe International Business School
| 2 years |
| Bing Xiang | M | 61 |
China Europe International Business School
| 2 years |
| Qing Yu Zhang | M | 55 |
China Europe International Business School
| 2 years |
| Jian Ming Shi | M | 55 |
China Europe International Business School
| 1 years |
| Qinseng Li | M | 63 |
China Europe International Business School
| 2 years |
| Wan Shan Wu | M | 61 |
China Europe International Business School
| 2 years |
| Fu Lin Ma | M | 60 |
China Europe International Business School
| 4 years |
| Jian Wei Zhang | M | 70 |
China Europe International Business School
| 2 years |
| Li Xiao | F | 60 |
China Europe International Business School
| 2 years |
| Hongquan Liu | M | 65 |
China Europe International Business School
| 2 years |
| Jian Wei Zhang | M | 67 |
China Europe International Business School
| 2 years |
| Jin-Ha Kim | M | 57 |
China Europe International Business School
| 2 years |
| Yongji Xiao | M | - |
China Europe International Business School
| 2 years |
| Hai Jun Wu | M | 62 |
China Europe International Business School
| 2 years |
| Zhen Yong Chang | M | 67 |
China Europe International Business School
| 2 years |
| Kang Rong Bao | M | 60 |
China Europe International Business School
| 2 years |
| Qi Bao Zheng | M | 66 |
China Europe International Business School
| 2 years |
| Zhong Mei Zou | M | 59 |
Peking Union Medical College
| 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 77 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Yong Qing Cheng
- Personal Network
